DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,034 filers reported holding DANAHER CORPORATION in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,237,137 | -0.4% | 154,120 | -3.7% | 0.67% | +2.1% |
| Q2 2023 | $38,398,930 | -7.4% | 159,996 | -2.8% | 0.65% | -14.0% |
| Q1 2023 | $41,475,815 | -7.1% | 164,560 | -2.1% | 0.76% | -10.9% |
| Q4 2022 | $44,624,208 | +6.9% | 168,127 | +4.1% | 0.85% | -10.8% |
| Q3 2022 | $41,737,000 | +1.8% | 161,569 | -0.1% | 0.95% | +3.6% |
| Q2 2022 | $41,015,000 | -16.6% | 161,761 | -3.5% | 0.92% | -3.9% |
| Q1 2022 | $49,201,000 | -9.6% | 167,713 | +1.4% | 0.96% | -7.4% |
| Q4 2021 | $54,405,000 | +1.0% | 165,344 | -6.5% | 1.04% | -4.9% |
| Q3 2021 | $53,851,000 | +9.4% | 176,869 | -3.6% | 1.09% | +10.1% |
| Q2 2021 | $49,223,000 | +15.6% | 183,402 | -3.0% | 0.99% | +5.9% |
| Q1 2021 | $42,580,000 | -4.3% | 189,152 | -5.6% | 0.93% | -9.0% |
| Q4 2020 | $44,502,000 | -5.7% | 200,309 | -8.6% | 1.02% | -12.8% |
| Q3 2020 | $47,202,000 | +19.5% | 219,184 | -1.9% | 1.18% | +12.9% |
| Q2 2020 | $39,515,000 | +41.4% | 223,438 | +10.7% | 1.04% | +7.3% |
| Q1 2020 | $27,947,000 | -7.6% | 201,880 | +2.5% | 0.97% | +17.6% |
| Q4 2019 | $30,239,000 | +5.1% | 196,993 | -1.1% | 0.83% | -3.3% |
| Q3 2019 | $28,782,000 | +0.5% | 199,250 | -0.6% | 0.85% | -3.6% |
| Q2 2019 | $28,644,000 | +7.0% | 200,393 | -1.4% | 0.89% | +7.8% |
| Q1 2019 | $26,768,000 | +44.7% | 203,168 | +13.3% | 0.82% | +19.7% |
| Q4 2018 | $18,494,000 | -13.8% | 179,344 | -9.2% | 0.69% | +2.4% |
| Q3 2018 | $21,453,000 | +7.9% | 197,434 | -2.0% | 0.67% | +8.8% |
| Q2 2018 | $19,885,000 | -9.3% | 201,503 | -10.0% | 0.62% | -4.3% |
| Q1 2018 | $21,933,000 | +43.5% | 224,008 | +36.0% | 0.64% | +33.3% |
| Q4 2017 | $15,287,000 | +17.3% | 164,691 | +8.4% | 0.48% | +13.3% |
| Q3 2017 | $13,037,000 | +5.5% | 151,976 | +3.8% | 0.43% | +2.9% |
| Q2 2017 | $12,353,000 | -0.2% | 146,377 | +1.2% | 0.42% | -1.7% |
| Q1 2017 | $12,373,000 | +5.9% | 144,661 | -3.7% | 0.42% | +5.0% |
| Q4 2016 | $11,689,000 | +3.4% | 150,171 | +4.2% | 0.40% | -1.0% |
| Q3 2016 | $11,302,000 | -17.4% | 144,180 | +6.4% | 0.41% | -19.9% |
| Q2 2016 | $13,683,000 | +6.9% | 135,473 | +0.4% | 0.51% | +5.8% |
| Q1 2016 | $12,796,000 | +7.2% | 134,897 | +5.0% | 0.48% | +6.2% |
| Q4 2015 | $11,937,000 | +15.7% | 128,521 | +6.2% | 0.45% | +10.3% |
| Q3 2015 | $10,313,000 | +1160.8% | 121,031 | +1165.6% | 0.41% | +1263.3% |
| Q2 2015 | $818,000 | -26.0% | 9,563 | -26.6% | 0.03% | -26.8% |
| Q1 2015 | $1,106,000 | +0.5% | 13,025 | +1.5% | 0.04% | -2.4% |
| Q4 2014 | $1,100,000 | +91.0% | 12,837 | +69.1% | 0.04% | +82.6% |
| Q3 2014 | $576,000 | -0.9% | 7,590 | +3.0% | 0.02% | 0.0% |
| Q2 2014 | $581,000 | +13.0% | 7,370 | +7.7% | 0.02% | +4.5% |
| Q1 2014 | $514,000 | -4.8% | 6,844 | -2.3% | 0.02% | -8.3% |
| Q4 2013 | $540,000 | +167.3% | 7,005 | +141.1% | 0.02% | +140.0% |
| Q3 2013 | $202,000 | – | 2,905 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |